FDA Inspection
Stephan A. Grupp, M.D., Ph.D.Stephan A. Grupp, M.D., Ph.D. – FDA Inspection, Apr 13, 2017
Record Details
This FDA Inspection record concerns Stephan A. Grupp, M.D., Ph.D., with an inspection on April 13, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Person
- Marcelo O. Mangalindan (Issuing Officer)
View Company Profile
ID · 16c88cce-10bf-425c-bd20-612bb21603b3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1009264
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Stephan A. Grupp, M.D., Ph.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2026 | Not classified | Philadelphia District Office | |
| May 2, 2013 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Stephan A. Grupp, M.D., Ph.D.
- FDA Inspection 1322502 - 2026-06-04
- FDA Inspection 829992 - 2013-05-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.